title: Fewer intraperitoneal adhesions with use of hyaluronic acid-carboxymethylcellulose membrane: a randomized clinical trial.
abstract: OBJECTIVE
  To assess the effectiveness of bioresorbable Seprafilm membrane in preventing abdominal adhesions in a prospective clinical randomized multicenter trial.
  
  
  BACKGROUND
  Adhesions occur frequently after abdominal operations and are a common cause of bowel obstruction, chronic abdominal pain, and infertility. To reduce the formation of adhesions, a mechanical barrier composed of hyaluronic acid and carboxymethylcellulose was developed, preventing adherence of tissues after abdominal surgery.
  
  
  METHODS
  Between April 1996 and September 1998, all patients requiring a Hartmann procedure for sigmoid diverticulitis or obstructed rectosigmoid were randomized to either intraperitoneal placement of the antiadhesions membrane under the midline during laparotomy and in the pelvis, or as a control. Direct visual evaluation of the incidence and severity of adhesions was performed laparoscopically at second-stage surgery for restoration of the continuity of the colon.
  
  
  RESULTS
  A total of 71 patients were randomized; of these, 42 could be evaluated. The incidence of adhesions did not differ significantly between the two groups, but the severity of adhesions was significantly reduced in the Seprafilm group both for the midline incision and for the pelvic area. Complications occurred in similar numbers in both groups.
  
  
  CONCLUSIONS
  Seprafilm antiadhesions membrane appears effective in reducing the severity of postoperative adhesions after major abdominal surgery, although the incidence of adhesions was not diminished. The authors recommend using Seprafilm when relaparotomy or second-look intervention is planned. Long-term studies are needed to assess the cost-effectiveness and value of Seprafilm in preventing bowel obstruction, chronic abdominal pain, and infertility.
authors.affiliation: Department of Surgery, University Hospital Rotterdam-Dijkzigt, Rotterdam, The Netherlands.
authors.forename: Wietske W
authors.initials: WW
authors.lastname: Vrijland
authors.forename: Larissa N L
authors.initials: LN
authors.lastname: Tseng
authors.forename: Heert J M
authors.initials: HJ
authors.lastname: Eijkman
authors.forename: Wim C J
authors.initials: WC
authors.lastname: Hop
authors.forename: Jack J
authors.initials: JJ
authors.lastname: Jakimowicz
authors.forename: Piet
authors.initials: P
authors.lastname: Leguit
authors.forename: Laurents P S
authors.initials: LP
authors.lastname: Stassen
authors.forename: Dingeman J
authors.initials: DJ
authors.lastname: Swank
authors.forename: Robert
authors.initials: R
authors.lastname: Haverlag
authors.forename: H Jaap
authors.initials: HJ
authors.lastname: Bonjer
authors.forename: Hans
authors.initials: H
authors.lastname: Jeekel
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001672:Biocompatible Materials / Q000627:therapeutic use*; D002266:Carboxymethylcellulose Sodium; D013505:Digestive System Surgical Procedures; D004238:Diverticulitis / Q000601:surgery; D005260:Female; D006801:Humans; D006820:Hyaluronic Acid; D007415:Intestinal Obstruction / Q000601:surgery; D008297:Male; D008567:Membranes, Artificial; D008875:Middle Aged; D011446:Prospective Studies; D000267:Tissue Adhesions / Q000517:prevention & control
chemical_list: D001672:Biocompatible Materials; D008567:Membranes, Artificial; C118198:Seprafilm; D006820:Hyaluronic Acid; D002266:Carboxymethylcellulose Sodium